John Cini

Founder at

Sonnet BioTherapeutics, Inc.

74 year

Health Technology

Consumer Services

Profile

John K.
Cini was the founder of Sonnet BioTherapeutics Holdings, Inc., founded in 2011, where the title held was Chief Scientific Officer from 2020 to 2025.
Dr. Cini is the founder of Sonnet BioTherapeutics, Inc., founded in 2015, holding the title of Chief Scientific Officer starting in 2015.
Former jobs include Executive Director at Medarex, Inc. and Vice President-Discovery & Development Sciences at Outlook Therapeutics, Inc. from 2011 to 2015.
Education includes a doctorate from the University of North Texas.

John Cini active positions

Companies	Position	Start
Sonnet BioTherapeutics, Inc. Sonnet BioTherapeutics, Inc. BiotechnologyHealth Technology Develops immuno-oncology therapeutics	Founder	2014-12-31

All active positions of John Cini

Former positions of John Cini

Companies	Position	End
SONNET BIOTHERAPEUTICS	Founder	2025-12-01
OUTLOOK THERAPEUTICS, INC.	Corporate Officer/Principal	2015-03-31
Medarex, Inc. Medarex, Inc. BiotechnologyHealth Technology Provides antibody and oncology drug development services	Director/Board Member	-

See the detail of John Cini's experience

Training of John Cini

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of John Cini's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	5
Medarex, Inc. Medarex, Inc. BiotechnologyHealth Technology Provides antibody and oncology drug development services	Health Technology
University of North Texas University of North Texas Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Outlook Therapeutics, Inc. Outlook Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures bevacizumab therapeutic products	Health Technology
Sonnet BioTherapeutics, Inc. Sonnet BioTherapeutics, Inc. BiotechnologyHealth Technology Develops immuno-oncology therapeutics	Health Technology
Sonnet BioTherapeutics Holdings, Inc. Sonnet BioTherapeutics Holdings, Inc. BiotechnologyHealth Technology Develops immuno-oncology therapeutics	Health Technology

See company connections